We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Verity Pharmaceuticals and Serum Institute of India (SII) have applied to distribute SII’s licensed version of AstraZeneca’s COVID-19 vaccine in Canada, potentially easing shortages as European manufacturing sites struggle to meet global demand.